|
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
|
 |
|
With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future.
|
|
|
Novartis’ Rhapsido has won approval in Europe, while Coartem Baby has received WHO prequalification.
|
|
|
The EMA’s CHMP has stated its positive opinions on three drugs for autoimmune, muscle wasting and rare genetic diseases.
|
|
|
Results provide evidence needed to challenge the step-through reimbursement requirements that have restricted Qulipta's uptake in Europe.
|
|
|
The manufacturing of the drug will be retained by TJ Biopharma at its site in Hangzhou, which would make felzartamab China’s first domestically produced anti-CD38 immunotherapy for multiple myeloma (MM).
|
|
